Top Medical Searches

AcelRx Pharma shares sink as FDA rejects opioid painkiller

(Reuters) – Shares of AcelRx Pharmaceuticals Inc plunged more than 60 percent on Thursday after the U.S. Food and Drug Administration declined to approve its opioid painkiller Dsuvia.

 Read more…

Be Sociable, Share!
October 12th, 2017 Posted in Drug
Copyright 2008 © Drugs and Diseases. Developed by Axilosoft
Home | About Us | Privacy Policy | Contact Us